← Open Payments lookup

JAYKUMAR MARADIA: Open Payments

NPI 1386254134 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,719 in 62 payments from 13 companies in 2025. Trend: 2023 $1,441 · 2024 $1,391 · 2025 $1,719

Food & beverage: $1,561Education: $157
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.15$449
Janssen Pharmaceuticals, Inc9$325
Neurocrine BioSciences, Inc.4$202
Otsuka America Pharmaceutical, Inc.9$177
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$153
ABBVIE INC.6$111
Alkermes, Inc.4$104
E.R. Squibb & Sons, L.L.C.3$75
Takeda Pharmaceuticals U.S.A., Inc.2$41
Axsome Therapeutics, Inc.1$25

Products named: AUSTEDO XR, INGREZZA, SPRAVATO, CAPLYTA, UZEDY, INVEGA SUSTENNA, VRAYLAR, ARISTADA.

Industry payments across CA — which companies pay providers there.